MADRIGAL PHARMACEUTICALS, INC. MDGL
CIK 0001157601
Form 4 transactions dated Sep 1, 2023 to Sep 26, 2026, as reported to the SEC.
Insider purchases & sales
- Purchased
- $139.67M
- Sold
- $299.72M
Sep 1, 2023 – Sep 11, 2026
Available records · partial months are marked ·
| Date | Insider | Activity | Trade value (USD) | % of prior holding | |
|---|---|---|---|---|---|
| 2023-12-15 | Waltermire Robert E. Senior VP, Chief Pharma Dev. | Sale | $477.00K 2,000 shares sold | 26.09% sold Direct holding | ▾ |
| 2023-12-14 | Waltermire Robert E. Senior VP, Chief Pharma Dev. | Sale | $465.00K 2,000 shares sold | 26.09% sold Direct holding | ▾ |
| 2023-12-14 | BAKER JULIAN · BAKER FELIX · BAKER BROS. ADVISORS LP · Baker Brothers Life Sciences LP · 667, L.P. · Baker Bros. Advisors (GP) LLC Director | Purchase | $4.71M 20,633 shares bought | Unavailable Indirect holding | ▾ |
| 2023-12-13 | BAKER JULIAN · BAKER FELIX · BAKER BROS. ADVISORS LP · Baker Brothers Life Sciences LP · 667, L.P. · Baker Bros. Advisors (GP) LLC Director | Purchase | $17.81M 81,159 shares bought | Unavailable Indirect holding | ▾ |
| 2023-12-13 | Waltermire Robert E. Senior VP, Chief Pharma Dev. | Sale | $563.50K 2,500 shares sold | 30.61% sold Direct holding | ▾ |
| 2023-12-12 | BAKER JULIAN · BAKER FELIX · BAKER BROS. ADVISORS LP · Baker Brothers Life Sciences LP · 667, L.P. · Baker Bros. Advisors (GP) LLC Director | Purchase | $7.55M 34,578 shares bought | Unavailable Indirect holding | ▾ |
| 2023-12-12 | Waltermire Robert E. Senior VP, Chief Pharma Dev. | Sale | $283.20K 1,300 shares sold | 18.66% sold Direct holding | ▾ |
| 2023-12-05 | Lynch Brian Joseph SVP and General Counsel | Sale | $227.33K 1,000 shares sold | 6.25% sold Direct holding | ▾ |
| 2023-12-04 | Lynch Brian Joseph SVP and General Counsel | Sale | $393.96K 1,800 shares sold | 10.71% sold Direct holding | ▾ |
| 2023-11-30 | Lynch Brian Joseph SVP and General Counsel | Sale | $613.73K 3,000 shares sold | 16.67% sold Direct holding | ▾ |
Showing 18 / 18 record groups in 2023. The complete set is available through the API.
Follow the people behind the trades.
Sign in to look up the full history beyond 3 years, use advanced screening & filtering, download CSV, and reach other datasets through the Akkru API.
- Download CSV
- Earlier filings
- Advanced screening & filtering
- API & AI access
＋ New accounts get free API credits to explore data beyond ownership filings.
For AI agents & developers
The initial HTML of this page carries its exact data as script#research-data (JSON): values, units, scope, preview limits and SEC sources. Read it directly, no script or API key needed; script#research-access says what needs an account. For the year shown, this page lists 18 of 18 purchase / sale groups and 24 of 24 other groups; the totals and the monthly series cover the whole window.
Without an account: the last 3 years, with the row caps stated on the page. A free account opens all history on file on these pages and the CSV of what a page shows. Rows beyond the caps and bulk retrieval go through the authenticated API / MCP.
MCP https://api.akkrudata.ai/mcp
list_insider_transactions
{"ticker":"MDGL","transaction_code":["P","S"],"transaction_form_type":"4","page_size":20}Connect to MCP with OAuth and follow the returned pagination. Credits and usage limits depend on the account.
- MCP endpoint
- https://api.akkrudata.ai/mcp
- API / MCP documentation
- /documents
- llms.txt
- /llms.txt
Sources, coverage & how to read this data
Figures are as reported to the SEC and merged with later amendments where Akkru could match them. Preview limits apply to what is listed, not to the totals, which come from the complete reported data. Nothing is zero-filled: a missing quarter or month is shown as missing.